$16.70
At close: May 16, 2:17 PM EDT
Comments
Loading...
Telix Pharmaceuticals Analyst Ratings and Price Targets | OTC:TLPPF | Benzinga
Telix Pharmaceuticals Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Telix Pharmaceuticals Corp from these most-recent analyst ratings.
Analyst Ratings for Telix Pharmaceuticals
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Telix Pharmaceuticals (TLPPF) stock?
There is no price target for Telix Pharmaceuticals
What is the most recent analyst rating for Telix Pharmaceuticals (TLPPF)?
There is no analyst for Telix Pharmaceuticals
When was the last upgrade for Telix Pharmaceuticals (TLPPF)?
There is no last upgrade for Telix Pharmaceuticals
When was the last downgrade for Telix Pharmaceuticals (TLPPF)?
There is no last downgrade for Telix Pharmaceuticals.
When is the next analyst rating going to be posted or updated for Telix Pharmaceuticals (TLPPF)?
There is no next analyst rating for Telix Pharmaceuticals.
Is the Analyst Rating Telix Pharmaceuticals (TLPPF) correct?
There is no next analyst rating for Telix Pharmaceuticals.
Browse analyst ratings and price targets on all stocks.
